DiscGenics Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series D
- (Cancelled)
- Investors
-
7
DiscGenics General Information
Description
Developer of a regenerative cell-based biologic drug therapies intended to alleviate pain and restore function in patients with degenerative diseases of the spine. The company's offers an allogeneic, injectable, and homologous cell therapy that utilizes biomedically engineered progenitor cells derived from intervertebral disc tissue to treat diseases of the disc, enabling patients to have access to a non-surgical and regenerative alternative for chronic back pain.
Contact Information
Website
www.discgenics.comCorporate Office
- 5940 West Harold Gatty Drive
- Salt Lake City, UT 84116
- United States
Corporate Office
- 5940 West Harold Gatty Drive
- Salt Lake City, UT 84116
- United States
DiscGenics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series D) | Cancelled | Clinical Trials - General | ||||
| 4. Later Stage VC (Series C) | 04-Dec-2020 | Completed | Clinical Trials - General | |||
| 3. Debt - PPP | 14-Apr-2020 | Completed | Clinical Trials - General | |||
| 2. Later Stage VC (Series B) | 22-Sep-2017 | $14.5M | $21.2M | Completed | Clinical Trials - General | |
| 1. Later Stage VC (Series A) | 30-Nov-2013 | $7.2M | $7.2M | Completed | Pre-Clinical Trials |
DiscGenics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Nonvoting Series C | ||||||||
| Nonvoting Series B | 53,387 | $0.001000 | $0.24 | $4.03 | $4.03 | 1x | $4.03 | 0.31% |
| Series B | 3,921,454 | $0.001000 | $0.24 | $4.03 | $4.03 | 1x | $4.03 | 22.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DiscGenics Comparisons
Industry
Financing
Details
DiscGenics Competitors (2)
One of DiscGenics’s 2 competitors is BioRestorative Therapies, a Corporation company based in Melville, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioRestorative Therapies | Corporation | Melville, NY | ||||
| Mesoblast | Corporation | Melbourne, Australia |
DiscGenics Patents
DiscGenics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023406314-A1 | Capped syringes and methods of sealing same | Pending | 01-Dec-2022 | ||
| EP-4626520-A1 | Capped syringes and methods of sealing same | Pending | 01-Dec-2022 | ||
| EP-4626520-A4 | Capped syringes and methods of sealing same | Pending | 01-Dec-2022 | ||
| US-20240181169-A1 | Capped syringes and methods of sealing same | Pending | 01-Dec-2022 | ||
| WO-2024119046-A1 | Capped syringes and methods of sealing same | Inactive | 01-Dec-2022 | A61J1/05 |
DiscGenics Signals
DiscGenics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CareNet | PE-Backed Company | Minority | ||
| Ci:z Investment | Corporate Venture Capital | Minority | ||
| Eagle Fund SP1 | Venture Capital | Minority | ||
| Medical Incubator Japan | Venture Capital | Minority | ||
| Saisei Ventures | Venture Capital | Minority |
DiscGenics FAQs
-
When was DiscGenics founded?
DiscGenics was founded in 2008.
-
Where is DiscGenics headquartered?
DiscGenics is headquartered in Salt Lake City, UT.
-
What is the size of DiscGenics?
DiscGenics has 40 total employees.
-
What industry is DiscGenics in?
DiscGenics’s primary industry is Drug Discovery.
-
Is DiscGenics a private or public company?
DiscGenics is a Private company.
-
What is DiscGenics’s current revenue?
The current revenue for DiscGenics is .
-
How much funding has DiscGenics raised over time?
DiscGenics has raised $73M.
-
Who are DiscGenics’s investors?
CareNet, Ci:z Investment, Eagle Fund SP1, Medical Incubator Japan, and Saisei Ventures are 5 of 7 investors who have invested in DiscGenics.
-
Who are DiscGenics’s competitors?
BioRestorative Therapies and Mesoblast are competitors of DiscGenics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process